MYP_085982
Basic Information
Pep19-2.5
Anticancer Cytotoxic anticancer activity Cytotoxic
Antimicrobial
Antimicrobial Antibacterial
Antimicrobial Antibacterial Anti-Gram-positive
Antiviral
Antiviral Anti-Hepatitis virus Anti-HBV
Antiviral Anti-Hepatitis virus Anti-HCV
Antiviral Anti-Herpesvirus Anti-HSV
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral entry inhibition
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Toxicity / Safety Cytotoxicity Cytotoxic
Venom / Toxin General toxin Cytotoxic
Standard
20 amino acids
C135H187N37O22S
Standard
Sequence
GCKKYRRFRWKFKGKFWFWG
Physicochemical Analysis
2712.23 Da
11.17
7.74
7.52
0.3872
-1.23
0.50
-0.30
37.13
0.00
0.4000
17990.00
17990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
999.62
-2.04
40.0
31.0
88.0
195.0
11.0
19.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0416185 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HBV Entry inhibition
Hepatitis B virus (HBV) | 293T cells
1 μg/mL
IC50
Mammalian: 30 h; Yeast: >20 h; E. coli: >10 h
FIRST PREV 1 2 3 4
Showing 1 records on this page · Page 4 of 4